AKT1 and non-small cell lung carcinoma: Treatment with LL28 also showed dose-dependent suppression of IGF1R, Src, and their downstream mediators, including FAK, MEK, and Akt, in A549, H1299, and H460 NSCLC cells (Fig. 2b and c).